Acro Biomedical Co Stock Technical Analysis
| ACBM Stock | USD 0.02 0.00 0.00% |
As of the 11th of February 2026, ACRO Biomedical shows the Mean Deviation of 91.66, variance of 142934.45, and Coefficient Of Variation of 812.4. ACRO Biomedical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the entity's future prices. Please confirm ACRO Biomedical coefficient of variation, as well as the relationship between the total risk alpha and skewness to decide if ACRO Biomedical is priced adequately, providing market reflects its regular price of 0.0222 per share. As ACRO Biomedical appears to be a penny stock we also recommend to validate its information ratio numbers.
ACRO Biomedical Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ACRO, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ACROACRO |
ACRO Biomedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ACRO Biomedical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ACRO Biomedical.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in ACRO Biomedical on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding ACRO Biomedical Co or generate 0.0% return on investment in ACRO Biomedical over 90 days. Acro Biomedical Co., Ltd. engages in developing and marketing of nutritional products More
ACRO Biomedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ACRO Biomedical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ACRO Biomedical Co upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1228 | |||
| Maximum Drawdown | 3071.43 |
ACRO Biomedical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ACRO Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ACRO Biomedical's standard deviation. In reality, there are many statistical measures that can use ACRO Biomedical historical prices to predict the future ACRO Biomedical's volatility.| Risk Adjusted Performance | 0.1085 | |||
| Jensen Alpha | 50.21 | |||
| Total Risk Alpha | 7.5 | |||
| Treynor Ratio | (1.05) |
ACRO Biomedical February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1085 | |||
| Market Risk Adjusted Performance | (1.04) | |||
| Mean Deviation | 91.66 | |||
| Coefficient Of Variation | 812.4 | |||
| Standard Deviation | 378.07 | |||
| Variance | 142934.45 | |||
| Information Ratio | 0.1228 | |||
| Jensen Alpha | 50.21 | |||
| Total Risk Alpha | 7.5 | |||
| Treynor Ratio | (1.05) | |||
| Maximum Drawdown | 3071.43 | |||
| Skewness | 8.12 | |||
| Kurtosis | 66.0 |
ACRO Biomedical Backtested Returns
ACRO Biomedical is out of control given 3 months investment horizon. ACRO Biomedical secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of risk over the last 3 months. We have analyzed sixteen different technical indicators, which can help you to evaluate if expected returns of 15.87% are justified by taking the suggested risk. Use ACRO Biomedical Mean Deviation of 91.66, coefficient of variation of 812.4, and Variance of 142934.45 to evaluate company specific risk that cannot be diversified away. ACRO Biomedical holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -44.52, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning ACRO Biomedical are expected to decrease by larger amounts. On the other hand, during market turmoil, ACRO Biomedical is expected to outperform it. Use ACRO Biomedical information ratio, skewness, as well as the relationship between the Skewness and day median price , to analyze future returns on ACRO Biomedical.
Auto-correlation | 0.00 |
No correlation between past and present
ACRO Biomedical Co has no correlation between past and present. Overlapping area represents the amount of predictability between ACRO Biomedical time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ACRO Biomedical price movement. The serial correlation of 0.0 indicates that just 0.0% of current ACRO Biomedical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
ACRO Biomedical technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
ACRO Biomedical Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for ACRO Biomedical across different markets.
About ACRO Biomedical Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ACRO Biomedical Co on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ACRO Biomedical Co based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on ACRO Biomedical price pattern first instead of the macroeconomic environment surrounding ACRO Biomedical. By analyzing ACRO Biomedical's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ACRO Biomedical's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ACRO Biomedical specific price patterns or momentum indicators. Please read more on our technical analysis page.
ACRO Biomedical February 11, 2026 Technical Indicators
Most technical analysis of ACRO help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ACRO from various momentum indicators to cycle indicators. When you analyze ACRO charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1085 | |||
| Market Risk Adjusted Performance | (1.04) | |||
| Mean Deviation | 91.66 | |||
| Coefficient Of Variation | 812.4 | |||
| Standard Deviation | 378.07 | |||
| Variance | 142934.45 | |||
| Information Ratio | 0.1228 | |||
| Jensen Alpha | 50.21 | |||
| Total Risk Alpha | 7.5 | |||
| Treynor Ratio | (1.05) | |||
| Maximum Drawdown | 3071.43 | |||
| Skewness | 8.12 | |||
| Kurtosis | 66.0 |
ACRO Biomedical February 11, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as ACRO stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | 0.00 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 0.02 | ||
| Day Typical Price | 0.02 | ||
| Price Action Indicator | 0.00 |
Other Information on Investing in ACRO Pink Sheet
ACRO Biomedical financial ratios help investors to determine whether ACRO Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ACRO with respect to the benefits of owning ACRO Biomedical security.